Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Biotec Pharmacon says Woulgan Biogel receives CE-marking


Friday, 4 Apr 2014 06:45am EDT 

Biotec Pharmacon ASA:Says the company's Woulgan Biogel has received CE -marking as an advanced medical device.Says Biotec BetaGlucans and its international partner Smith & Nephew will immediately commence market evaluation trials.Biotec BetaGlucans AS is a wholly-owned subsidiary of Biotec Pharmacon ASA. 

Company Quote

18.0
0.1 +0.56%
9:33am EDT